Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa exploratory trial of pseudoginsenoside GQ injection for stable angina
CTR20191009Phase 2Active
- Sponsor
- Jilin Huakang Pharmaceutical
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pseudoginsenoside gq in stable angina, coronary arteriosclerosis, sponsored by Jilin Huakang Pharmaceutical. Started May 2019; status: active.
02
Drugs
pseudoginsenoside gq
03
Conditions
stable anginacoronary arteriosclerosis
Beyond the preview
Go deeper on CTR20191009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191009.